NCT04375384 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04375384
Title	Study to Evaluate Effect of Cetuximab Given as Single Agent After Immunotherapy
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Wake Forest University Health Sciences
Indications	head and neck squamous cell carcinoma
Therapies	Cetuximab
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Wake Forest Baptist Comprehensive Cancer Center	RECRUITING	Winston-Salem	North Carolina	27157	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04375384Clinical Trial Detail